Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.34
+0.11 (1.03%)
At close: Feb 11, 2026, 4:00 PM EST
10.36
+0.02 (0.24%)
After-hours: Feb 11, 2026, 4:32 PM EST
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $588.72 million as of February 11, 2026. Its market cap has increased by 105.49% in one year.
Market Cap
588.72M
Enterprise Value
385.92M
1-Year Change
105.49%
Ranking
Category
Stock Price
$10.34
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $588.72M, a decrease of -73.31%. That is a compound annual growth rate of -23.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 582.74M | 9.06% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 619.96M |
| Altimmune | 609.88M |
| Alpha Tau Medical | 606.23M |
| CorMedix | 605.89M |
| LB Pharmaceuticals | 603.13M |
| MeiraGTx Holdings | 598.05M |
| Ginkgo Bioworks Holdings | 574.05M |
| ProKidney | 562.56M |